Novartis

SIMULECT

Manufacturer:

Novartis

Simulect HCPCS:

J0480

HCPCS Code Descriptor:

Injection, basiliximab, 20 mg

Category:

J Code

Simulect NDCs:

00078-0393-61, 00078-0331-84

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Simulect CPT Codes:

Potential CPT administration codes for Simulect can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Simulect:

SIMULECT is an Immunosuppressant drug manufactured by Novartis and administered via the Intravenous route of administration. The J Code: J0480 is aligned to the drug SIMULECT.

ACCESS PRICING AND MORE BY REGISTERING

J0480 Added Date:

January 1, 2006

J0480 Effective Date:

January 1, 2006

J0480 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Simulect billing and coding information.
Our team did not identify a source for Simulect patient assistance information. Please reach out to our team if you feel that this is a mistake.
SIMULECT prescribing information can be found at the link below:
Information regarding SIMULECT’s side effects can be found at MedlinePlus